A Study to Assess Safety and Efficacy of SOT201 in Patients With Advanced/Metastatic Cancer

A Study to Assess Safety and Efficacy of SOT201 in Patients With Advanced/Metastatic Cancer
Conditions: Advanced Solid Tumor; Metastatic Solid Tumor

Interventions: Drug: SOT201

Sponsors: SOTIO Biotech AG

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 11, 2023Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments